Our current research programs use these and related technologies to focus on cancer, infectious diseases including HIV/AIDS and tuberculosis, cystic fibrosis, asthma, and neurodegenerative disorders, all underpinned by innovative programs in vector development, gene discovery, and clarification of underlying disease mechanisms.